IGC Pharma, Inc. (IGC)
Official siteHEALTHCARE • BIOTECHNOLOGY • AMEX
Market Cap: $20.54M
Last updated: Nov 17, 2026 at 11:05 AM ET
IGC Pharma, Inc. (IGC) Earnings: Report Dates and Results
In the quarter ended Sep 30, 2026, IGC Pharma reported EPS of -$0.02, in line with the -$0.02 estimate. It beat the EPS estimate in 3 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
IGC's report for the quarter ending Dec 31, 2026 is not on the earnings calendar yet.
Earnings History
Of the 13 quarters below that had an estimate, IGC beat 4, missed 3 and matched 6. Revenue for the quarter ended Sep 30, 2026 was $328000, up 71.7% from $191000 a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.02 | -$0.02 | -$0.02 - -$0.02 | 0.00% | In line | N/A | 1 | 0 up, 0 down | Nov 6, 2026 | $328000 |
| Jun 30, 2026 | -$0.03 | -$0.02 | -$0.02 - -$0.02 | -50.00% | Miss | N/A | 2 | 0 up, 0 down | Aug 14, 2026 | $265000 |
| Mar 31, 2026 | -$0.02 | -$0.02 | -$0.02 - -$0.02 | 0.00% | In line | N/A | 2 | 0 up, 0 down | Apr 3, 2026 | $317000 |
| Dec 31, 2025 | -$0.02 | -$0.02 | -$0.02 - -$0.02 | 0.00% | In line | N/A | 1 | 1 up, 0 down | Feb 18, 2026 | $350000 |
| Sep 30, 2025 | -$0.02 | -$0.02 | -$0.02 - -$0.02 | 0.00% | In line | N/A | 2 | 1 up, 0 down | Nov 14, 2025 | $191000 |
| Jun 30, 2025 | -$0.01 | -$0.03 | -$0.03 - -$0.02 | +50.67% | Beat | N/A | 2 | 0 up, 0 down | Aug 14, 2025 | $328000 |
| Mar 31, 2025 | -$0.01 | -$0.02 | -$0.02 - -$0.02 | +50.00% | Beat | N/A | 2 | 1 up, 0 down | Jun 27, 2025 | $330000 |
| Dec 31, 2024 | -$0.02 | -$0.03 | -$0.03 - -$0.03 | +33.33% | Beat | N/A | 1 | 1 up, 0 down | Feb 14, 2025 | $257000 |
| Sep 30, 2024 | -$0.02 | -$0.03 | -$0.03 - -$0.02 | +33.33% | Beat | N/A | 2 | 0 up, 0 down | Nov 12, 2024 | $412000 |
| Jun 30, 2024 | -$0.03 | -$0.03 | -$0.03 - -$0.02 | 0.00% | In line | N/A | 2 | 1 up, 0 down | Aug 8, 2024 | $330000 |
| Mar 31, 2024 | -$0.40 | -$0.04 | -$0.04 - -$0.04 | -900.00% | Miss | N/A | 1 | 0 up, 0 down | Jun 24, 2024 | $295000 |
| Dec 31, 2023 | -$0.05 | -$0.04 | N/A | -25.00% | Miss | N/A | N/A | N/A | Feb 14, 2024 | $204000 |
| Sep 30, 2023 | -$0.05 | -$0.05 | N/A | 0.00% | In line | N/A | N/A | N/A | Nov 9, 2023 | $291000 |
| Jun 30, 2023 | -$0.04 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jul 7, 2023 | $555000 |
| Mar 31, 2023 | -$0.08 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jun 30, 2023 | $165000 |
| Dec 31, 2022 | -$0.04 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Feb 14, 2023 | $332000 |
| Sep 30, 2022 | -$0.05 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 1, 2022 | $202000 |
| Jun 30, 2022 | -$0.05 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 8, 2022 | $212000 |
| Mar 31, 2022 | -$0.13 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jun 22, 2022 | $199000 |
| Dec 31, 2021 | -$0.05 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Feb 10, 2022 | $142000 |
| Sep 30, 2021 | -$0.09 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Oct 29, 2021 | $56000 |
| Jun 30, 2021 | -$0.04 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 11, 2021 | N/A |
| Mar 31, 2021 | -$0.07 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jun 14, 2021 | N/A |
| Dec 31, 2020 | -$0.06 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Feb 12, 2021 | $108000 |
| Sep 30, 2020 | -$0.04 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 20, 2020 | $125000 |
| Jun 30, 2020 | -$0.05 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jul 13, 2020 | $584000 |
| Mar 31, 2020 | -$0.08 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jun 17, 2020 | $29000 |
| Dec 31, 2019 | -$0.04 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Feb 10, 2020 | $573000 |
| Sep 30, 2019 | -$0.03 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 6, 2019 | $1.82M |
| Jun 30, 2019 | -$0.03 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 9, 2019 | $1.65M |
| Mar 31, 2019 | -$0.04 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jun 17, 2019 | $1.54M |
| Dec 31, 2018 | -$0.03 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Feb 12, 2019 | $1.28M |
| Sep 30, 2018 | -$0.03 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Oct 16, 2018 | $811000 |
| Jun 30, 2018 | -$0.02 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 2, 2018 | $1.48M |
| Mar 31, 2018 | -$0.02 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jun 21, 2018 | $1.14M |
| Dec 31, 2017 | -$0.02 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Feb 20, 2018 | $762000 |
| Sep 30, 2017 | -$0.01 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 20, 2017 | $235000 |
| Jun 30, 2017 | -$0.01 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jul 14, 2017 | $52926 |
| Mar 31, 2017 | -$0.02 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jun 30, 2017 | N/A |
| Dec 31, 2016 | -$0.04 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Feb 21, 2017 | $249801 |
Annual EPS
EPS for the fiscal year ended Mar 31, 2026 was -$0.07, after -$0.08 the year before. It was -$0.08 for the year ended Mar 31, 2017, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Mar 31, 2026 | -$0.07 | N/A |
| Mar 31, 2025 | -$0.08 | N/A |
| Mar 31, 2024 | -$0.54 | N/A |
| Mar 31, 2023 | -$0.22 | N/A |
| Mar 31, 2022 | -$0.31 | N/A |
| Mar 31, 2021 | -$0.22 | N/A |
| Mar 31, 2020 | -$0.18 | N/A |
| Mar 31, 2019 | -$0.12 | N/A |
| Mar 31, 2018 | -$0.06 | N/A |
| Mar 31, 2017 | -$0.08 | N/A |
Frequently Asked Questions About IGC
Did IGC beat earnings estimates last quarter?
IGC Pharma reported EPS of -$0.02 for the quarter ended Sep 30, 2026, in line with the -$0.02 estimate.
What EPS do analysts expect from IGC next quarter?
The consensus EPS estimate for IGC Pharma for the quarter ending Dec 31, 2026 is -$0.02 from 1 analyst, with estimates from -$0.02 to -$0.02.
How often does IGC beat earnings estimates?
IGC Pharma beat the EPS estimate in 3 of the last 8 quarters, with an average surprise of +10.50%.
IGC pages: Overview, Earnings, Forecast, Financials, Competitors